Abstract:The biological impact of NAD boosting on aging and cellular senescence is not completely understood. It appears that NAD is necessary for senescent cell function. Therefore, NAD boosting may increase senescence‐induced dysfunction. Combination of NAD boosters with senolytic therapy may be a promising approach to improve NAD‐targeted interventions, potentially benefiting age‐related diseases. However, no studies on this combination therapy have been reported yet. The geroscience hypothesis proposes that addressing the biology of aging could directly prevent the onset or mitigate the severity of multiple chronic diseases. Understanding the interplay between key aspects of the biological hallmarks of aging is essential in delivering the promises of the geroscience hypothesis. Notably, the nucleotide nicotinamide adenine dinucleotide (NAD) interfaces with several biological hallmarks of aging, including cellular senescence, and changes in NAD metabolism have been shown to be involved in the aging process. The relationship between NAD metabolism and cellular senescence appears to be complex. On the one hand, the accumulation of DNA damage and mitochondrial dysfunction induced by low NAD+ can promote the development of senescence. On the other hand, the low NAD+ state that occurs during aging may inhibit SASP development as this secretory phenotype and the development of cellular senescence are both highly metabolically demanding. However, to date, the impact of NAD+ metabolism on the progression of the cellular senescence phenotype has not been fully characterized. Therefore, to explore the implications of NAD metabolism and NAD replacement therapies, it is essential to consider their interactions with other hallmarks of aging, including cellular senescence. We propose that a comprehensive understanding of the interplay between NAD boosting strategies and senolytic agents is necessary to advance the field.

Boosting NAD ameliorates hematopoietic impairment linked to short telomeres in vivo

Re-equilibration of imbalanced NAD metabolism ameliorates the impact of telomere dysfunction

NAD-Linked Metabolism and Intervention in Short Telomere Syndromes and Murine Models of Telomere Dysfunction

NAD+ Repletion Improves Mitochondrial and Stem Cell Function and Enhances Life Span in Mice

The Impacts of Short-Term NMN Supplementation on Serum Metabolism, Fecal Microbiota, and Telomere Length in Pre-Aging Phase

Rejuvenating Aged Hematopoietic Stem Cells Through Improvement of Mitochondrial Function

Nicotinamide riboside attenuates age-associated metabolic and functional changes in hematopoietic stem cells

Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan

Telomere Dysfunction Induces Environmental Alterations Limiting Hematopoietic Stem Cell Function and Engraftment

Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure

The use of progeroid DNA repair-deficient mice for assessing anti-aging compounds, illustrating the benefits of nicotinamide riboside

NAD+ precursors prolong survival and improve cardiac phenotypes in a mouse model of Friedreich's Ataxia

NAD metabolism: Role in senescence regulation and aging

Long-term NMN treatment increases lifespan and healthspan in mice in a sex dependent manner

Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice.

Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study

A novel nutraceutical formulation increases telomere length and activates telomerase activity in middle‑aged rats

Nicotinamide Adenine Dinucleotide Precursor Suppresses Hepatocellular Cancer Progression in Mice

Bacteria boost mammalian host NAD metabolism by engaging the deamidated biosynthesis pathway

Telomerase reverse transcriptase and neurodegenerative diseases

NAD+ supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cells